Medycyna Wieku Rozwojowego

Analiza g´stoÊci naczyniowej oraz ekspresji Êródb∏onkowo-naczyniowego czynnika wzrostu (VEGF)
755
11. Lewy-Trenda I.: Nowotwory a angiogeneza. Pol. Merk. Lek., 2002, 13, 75, 225-228.
12. Canette A., Navarro S., Bermudez J. i wsp.: Angiogenesis in neuroblastoma: relationship
to survival and other prognostic factors in a cohort of neuroblastoma patients. J. Clin. Oncol.,
2000, 18, 27-34.
13. Meitar D., Crawford S.E., Rademaker A.W. i wsp.: Tumour angiogenesis correlates with
metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin.
Oncol., 1996, 14, 405-414.
14. Shimada H., Ambros I.M., Dehner L.P. i wsp.: Neuroblastoma Pathology Classification
(the Shimada system). Cancer, 1999, 86, 354-372.
15. Brodeur G.M., Pritchard J., Berthold F. i wsp.: Revision of the international criteria for neuroblastoma
diagnosis, staging and response to treatment. J. Clin. Oncol., 11, 1993,1466-1477.
16. Folkman J.: Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 1971, 285,
1182-1186.
17. Fakhari M., Pullirsch D., Paya K. i wsp.: Upregulation of Vascular Endothelial Growth
Factor Receptors is associated with advanced Neuroblastoma. J. Ped. Surg., 2002, 37, 4, 582-587.
18. Vermoulen P.B., Gasparini G., Fox S.B. i wsp.: Quantification of angiogenesis in solid human
tumours. An international concessus on the methodology and criteria of evaluation. Eur.
J. Cancer, 1996, 32A, 2472-2484.
19. Weidner N.: Intratumor microvessels density as a prognostic factor in cancer. Am. J. Pathol.,
1995, 147, 9-19.
20. Akslen L.A., Livolsi V.A.: Increased angiogenesis in papillary thyroid carcinoma but lack
of prognostic importance. Hum. Pathol., 2000, 31, 4, 439-42.
21. Eggert A., Ikegaki N., Kwiatkowski J. i wsp.: High-level expression of angiogenic factors is
associated with advanced stage in human nuroblastomas. Clin. Cancer. Res., 2000, 6, 1900-1908.
22. Tonini G.P., Romani M.: Genetic and epigenetic alterations in neuroblastoma. Cancer
Lett., 2003, 197, 69-73.
23. Ribatti D., Alessandri G., Vacca A. i wsp.: Human neuroblastoma cells produce extracellular
matrix degradating enzymes, induce endothelial cell proliferation and are angiogenic in vivo.
Int. J. Cancer, 1998, 29, 449-454.
24. Jogi A., Ora I., Nilsson H. i wsp.: Hypoxia alters gene expression in human neuroblastoma
cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA,
2002, 14, 7021-7026.
25. Huang D., Rutkowski J.L., Brodeur G.M. i wsp.: Schwann cell-conditioned medium inhibits
angiogenesis in vitro and in vivo. Med. Ped. Oncol., 2000, 35, 590-592.
26. Gasparini G.: Angiogenesis research up to 1996. A commentary on the state of art and
suggestions for future studies. Eur. J. Cancer, 1996, 32 A, 14, 2379- 2385.
27. Backman U., Svenson A., Christofferson R.: Importance of vascular endothelial growth
factor A in the progression of experimental neuroblastoma. Angiogenesis, 2002 5, 4, 267-274.
28. Fukuzawa M. Sugiura H., Koshinada T. i wsp.: Expression of vascular endothelial growth
factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. J. Pediatr.
Surg., 2002, 37,12, 1747-1750.
29. Rossler J., Breit S., Havers W. i wsp.: Vascular endothelial growth factor expression in human
neuroblastoma; up-regulation by hypoxia. Med. J. Cancer., 1999, 81, 113-117.
El˝bieta Dro˝yƒska
Klinika Pediatrii, Hematologii,
Onkologii i Endokrynologii AMG
ul. D´binki 7, 80-211 Gdaƒsk
tel/fax: 058 349 28 63
e-mail: edrozd@wp.pl